Faculty Opinions recommendation of Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
2009 ◽
Vol 4
(2)
◽
pp. 113-119
◽
2003 ◽
Vol 29
(4)
◽
pp. 6S53-6S61
◽
2020 ◽
Vol 14
(5)
◽
pp. 1217-1224
Keyword(s):
2018 ◽
Vol 3
(1)
◽
pp. 15
◽
Keyword(s):
2010 ◽
Vol 52
◽
pp. S4-S10
◽